UMBILICA CATHETER 1272.04

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2020-02-18 for UMBILICA CATHETER 1272.04 manufactured by Vygon.

Event Text Entries

[179783718] The failed sample will be returned to vygon for device evaluation as part of the complaint investigation. The results of this investigation are still pending, and will be communicated to fda within 30 days of its conclusion.
Patient Sequence No: 1, Text Type: N, H10


[179783719] (b)(6) week gestation infant born on (b)(6). Umbilical venous catheter inserted on the day of birth. On (b)(6) referred from hospital to (b)(6) with an acute abdomen. Tpn extravasation diagnosed at (b)(6) secondary to liver and abdominal extravasation of tpn from umbilical venous catheter. Drained soon after admission to (b)(6) with surgical peritoneal drain. Umbilical catheter removed. This catheter stays 5 days in situ. Baby subsequently went on to develop intractable renal failure and necrotising enterocolitis with perforation needing laparotomy. Palliative care commenced and intensive care withdrawn on the (b)(6). Baby died on (b)(6) 2020.
Patient Sequence No: 1, Text Type: D, B5


[187468506] We have received the involved umbilical catheter. During the investigation, the returned device functioned normally, with no signs of leakage identified when flushing either lumen of the device. Unfortunately, we are unaware as to how the location of the device was confirmed after placement. The instructions for use (ifu) provided with the device advise: "control of positioning: always check the location of the catheter by radiography. For umbilical arterial catheterization, the catheter can be sited either in the high position between thoracic vertebrae t6 and t9 or the low position at l3 to l5 level though the higher position is associated with lower complication rates. For umbilical venous catheterization, the catheter tip should be placed beyond the ductus venosus in the central venous system (inferior vena cava). " the returned catheter is conform, there is no defect. On evaluation of our historical datas since 2017, we can confirm that we have not received any additional reports of a similar nature for this product. The root cause of this adverse event is not linked to the quality of our device.
Patient Sequence No: 1, Text Type: N, H10


[187468507] (b)(6) gestation infant born on (b)(6). Umbilical venous catheter inserted on the day of birth. On (b)(6) referred from hospital to (b)(6) with an acute abdomen. Tpn extravasation diagnosed at (b)(6) to liver and abdominal extravasation of tpn from umbilical venous catheter. Drained soon after admission to (b)(6) with surgical peritoneal drain. Umbilical catheter removed. This catheter stays 5 days in situ. Baby subsequently went on to develop intractable renal failure and necrotising enterocolitis with perforation needing laparotomy. Palliative care commenced and intensive care withdrawn on the (b)(6). Baby died on (b)(6) 2020.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2245270-2020-00008
MDR Report Key9720395
Report SourceCOMPANY REPRESENTATIVE
Date Received2020-02-18
Date of Report2020-02-17
Date of Event2020-01-12
Date Mfgr Received2020-02-05
Date Added to Maude2020-02-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA3
Event Location3
Manufacturer ContactFREDA LACROIX
Manufacturer Street2750 MORRIS ROAD
Manufacturer CityLANSDALE, PA
Manufacturer CountryUS
Manufacturer Phone4735414237
Manufacturer G1VYGON
Manufacturer Street5 RUE ADELINE
Manufacturer CityECOUEN 95440
Manufacturer CountryFR
Manufacturer Postal Code95440
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameUMBILICA CATHETER
Generic NameUMBILICAL CATHETER
Product CodeFOS
Date Received2020-02-18
Model Number1272.04
Lot NumberUNKNOWN
Device AvailabilityY
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerVYGON
Manufacturer Address5 RUE ADELINE ECOUEN 95440 FR 95440


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2020-02-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.